The present invention relates to a process for the manufacture of intermediates that may be used for the manufacture of ARBs (also called angiotension II receptor antagonists or AT1 receptor antagonists) comprising as a common structural feature a (1H-tetrazol-5-yl)-biphenyl ring.

 
Web www.patentalert.com

< Method of forming stack layer and method of manufacturing electronic device having the same

> Metal resistant plants and phytoremediation of environmental contamination

> Method and device for concentrating light in optoelectronic devices using resonant cavity modes

~ 00599